Major Depressive Disorder (MDD) is a leading cause of disability globally in both developed and developing nations.

This is the first book to comprehensively explore the domain of cognition in MDD. The literature describing cognitive dysfunction is reviewed with particular focus on clinical determinants, pathophysiology, and causative factors. The patient subpopulations most susceptible are defined. A summary of contemporary assessment tools for research and clinical purposes is provided. Multimodality treatments and prevention strategies are described.

This book is an invaluable resource for psychiatrists, neuropsychologists and other members of the mental health team, as well as for policy makers, vocation rehabilitation experts, disability providers, and other stakeholders interested in improving health outcomes in MDD.

This is a comprehensive, up-to-date, and evidence-based review of women's mental health.

It starts by considering the social and cultural contexts of women's lives today, before addressing how developmental aspects pertain to mental health, exploring biological, evolutionary, and psychosocial parameters. The heart of the book contains a series of chapters with a clinical emphasis.

The scope of this book is intended to be broad and aimed at a clinical audience, including psychiatrists and general physicians, as well as mental health nurses, psychologists social workers, and occupational therapists.

The critical relationship between antibodies and infectious diseases has spawned entire related fields of study. Antibodies for Infectious Diseases presents perspectives from leading research scientists and summarizes the amazing progress in this area into a single definitive source.

Antibodies for Infectious Diseases is a comprehensive reference for researchers, pharmaceutical developers, and health care professionals on the status of the development of antibody-based therapies for treating infectious diseases. It is useful as supplemental reading for upper level life sciences students.

Psychotic illness is managed and treated with best results when it is recognized at the earliest stages of a person developing the disorder, or when that person is identified as being at high risk of doing so. Describing a stage-specific model highlighting the risk, the clinical and biological factors present during the development of the illness, and the best treatments available for each of these stages, this new edition will guide practitioners and researchers in the adoption of carefully planned management strategies fully integrating treatment with prevention, issues such as resistance to drugs and vocational recovery are covered, with related topics such as service organization and community education. This is essential reading for all those involved in the care of people with early psychotic illness, or those responsible for the organization of services.